Biomea Fusion, Inc. Effective Income Tax Rate Reconciliation, Tax Credit, Percent
Biomea Fusion, Inc. (BMEA) reported Effective Income Tax Rate Reconciliation, Tax Credit, Percent of -2.90% for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Expense Statement › Income Tax
us-gaap:EffectiveIncomeTaxRateReconciliationTaxCredits · last filed 2026-03-24
- Biomea Fusion, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2024 was -2.90%.
- Biomea Fusion, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2023 was -4.10%.
- Biomea Fusion, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2022 was -1.10%, a 650.00% decline from fiscal 2021.
- Biomea Fusion, Inc. effective income tax rate reconciliation, tax credit, percent for fiscal 2021 was 0.20%.
| Period end | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month | Effective Income Tax Rate Reconciliation, Tax Credit, Percent 12 month as first filed |
|---|---|---|
| 2024-12-31 | -2.90% 10-K · filed 2026-03-24 | |
| 2023-12-31 | -4.10% 10-K · filed 2026-03-24 | 4.10% 10-K · filed 2024-03-28 |
| 2022-12-31 | -1.10% 10-K · filed 2025-03-31 | 1.10% 10-K · filed 2023-03-28 |
| 2021-12-31 | 0.20% 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Polaryx Therapeutics, Inc. (PLYX) | United States | $0.106B | |
| Equillium, Inc. (EQ) | United States | $0.109B | -11.27 |
| GENELUX Corp (GNLX) | United States | $0.110B | -3.83 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| ProMIS Neurosciences Inc. (PMN) | $0.102B | ||
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Milestone Pharmaceuticals Inc. (MIST) | $0.098B | -2.00 | |
| CITIUS ONCOLOGY, INC. (CTOR) | United States | $0.097B | -1.49 |
| Anixa Biosciences Inc (ANIX) | United States | $0.096B |